Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ABL.DE
BUYAbbott Laboratories · Healthcare · United States · $164.9B · Avg Vol: $116K/d
COMPANY DESCRIPTION
Abbott Laboratories is a highly diversified global healthcare giant developing medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals. Its massive competitive moat is sustained by market-leading technologies, such as the FreeStyle Libre continuous glucose monitor, and significant regulatory barriers to entry. Abbott is a resilient, blue-chip market leader with a long history of delivering consistent dividend growth.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.7B | 40.1B | 42.0B | 44.3B | 0.5% | 46.6B | 50.3B | 54.6B | 11.0% |
| EPS | 3.99 | 3.30 | 7.74 | 3.76 | -2.0% | 3.58 | — | — | — |
| Shares | 1.7B | 1.7B | 1.7B | 1.7B | -0.1% | 1.7B | — | — | — |
| Debt | 17.7B | 15.6B | 15.0B | 13.9B | -7.9% | 34.1B | — | — | — |
| Equity | 36.7B | 38.6B | 47.7B | 52.1B | 12.4% | — | — | — | — |
| Op CF | 9.6B | 7.3B | 8.6B | 9.6B | -0.1% | 9.6B | — | — | — |
| Inv CF | -1.7B | -3.1B | -2.3B | -2.4B | — | — | — | — | — |
| Fin CF | -7.6B | -7.1B | -5.4B | -6.3B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ABL.DE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ABL.DE | Abbott Laboratories(you) | $164.9B | 70 | BUY |
| SYK | Stryker Corporation | $126.6B | 67 | BUY |
| 2M6.DE | Medtronic plc | $104.4B | 73 | BUY |
| BSX.MX | Boston Scientific Corporation | $66.0B | 63 | HOLD |
| EW | Edwards Lifesciences Corporation | $47.6B | 72 | BUY |
| GEHC.MX | GE HealthCare Technologies Inc. | $27.5B | 67 | BUY |
| SHL.DE | Siemens Healthineers AG | $43.6B | 56 | HOLD |
| 300760.SZ | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | $23.9B | 66 | BUY |
| DXCM | DexCom, Inc. | $27.6B | 83 | STRONG BUY |
| STE | STERIS plc | $20.9B | 81 | STRONG BUY |
Peer medians: ROE 2.0% · P/E 23.4x · Gross margin 50.0%